Household Healthcare Sector

Avalo Therapeutics

Market Cap: US$41.0m

A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.

CRUSHMETRIC Group

Market Cap: UK£30.5m

A design and production company, integrates shape changing technology into catalogue of products in Hong Kong, Mainland China, and Singapore.

Kronos Bio

Market Cap: US$40.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States.

Pacific Edge

Market Cap: NZ$69.0m

A cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally.

Rani Therapeutics Holdings

Market Cap: US$40.7m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Karyopharm Therapeutics

Market Cap: US$40.6m

A commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States.

Vitasora Health

Market Cap: AU$63.1m

An e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States.

MedMira

Market Cap: CA$56.1m

A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally.

Atara Biotherapeutics

Market Cap: US$40.4m

Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.

America Great Health

Market Cap: US$40.3m

Operates as a biotechnology company in the United States.

Bioqual

Market Cap: US$40.2m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Grace Therapeutics

Market Cap: US$40.0m

Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.

Sharp Therapeutics

Market Cap: CA$55.4m

A preclinical-stage drug discovery company, developes therapeutics for genetic diseases.

Camp4 Therapeutics

Market Cap: US$39.9m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Global Innovative Platforms

Market Cap: US$39.8m

Engages in the business of testing breath to detect and assist in the treatment of disease.

New Green Hemp

Market Cap: US$39.8m

New Green Hemp Inc. cultivates and sells hemp products.

LTR Pharma

Market Cap: AU$61.5m

A biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

Cryo-Cell International

Market Cap: US$39.2m

Engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use.

Annovis Bio

Market Cap: US$39.2m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

Futura Medical

Market Cap: UK£29.2m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Comjoyful International

Market Cap: US$39.1m

Operates and manages healthcare clubs in China.

ZYUS Life Sciences

Market Cap: CA$53.5m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

Spero Therapeutics

Market Cap: US$38.3m

A clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.

Daxor

Market Cap: US$38.3m

A medical device company, provides blood volume measurement technology focused on blood volume testing.

NurExone Biologic

Market Cap: CA$52.3m

Operates as a pharmaceutical technology company.

Boundless Bio

Market Cap: US$37.2m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Defence Therapeutics

Market Cap: CA$51.4m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

Renalytix

Market Cap: UK£27.3m

Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.

Iterum Therapeutics

Market Cap: US$36.6m

A pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States.

Propanc Biopharma

Market Cap: US$36.6m

A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Estrella Immunopharma

Market Cap: US$36.5m

A clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.

electroCore

Market Cap: US$36.5m

A bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.

Helix BioPharma

Market Cap: CA$50.4m

Operates as an immune-oncology company in Canada.

Oncolytics Biotech

Market Cap: CA$50.2m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

Quantum BioPharma

Market Cap: CA$50.1m

Operates as a biopharmaceutical company.

Acrivon Therapeutics

Market Cap: US$36.1m

A clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform.